Detalhe da pesquisa
1.
Cost-effectiveness analysis of mecapegfilgrastim and recombinant human granulocyte stimulating factor for primary prophylaxis of chemotherapy-induced neutropenia in non-small cell lung cancer.
Int J Clin Pharmacol Ther
; 62(3): 115-121, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263810
2.
Use of a dose-response model to guide future clinical trial of benvitimod cream to treat mild and moderate psoriasis.
Int J Clin Pharmacol Ther
; 54(2): 87-95, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26709597
3.
A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease.
Front Pharmacol
; 13: 892526, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36176448